Trip.com Group Initiates Management Trial for "No-Questions-Asked Personal Leave" with Annual Cap of 45 Days

Deep News
04/07

Trip.com Group announced today that it will launch a one-year management experiment on "no-questions-asked personal leave" in select business units starting May 1, 2026. The trial will employ a randomized controlled study methodology. Approximately 6,000 employees will be randomly assigned to either an "experimental group" or a "control group." During the trial period, employees in the experimental group will receive an additional annual allowance of up to 45 days of "no-questions-asked personal leave," on top of existing paid leave entitlements. Employees within the group may apply to use this leave at any time based on personal needs, without having to provide specific reasons. It is important to note that compensation and attendance policies during "no-questions-asked personal leave" will align with the company’s current personal leave system, with the key difference being the "no-questions-asked" aspect, emphasizing greater employee autonomy. The company aims to explore how granting employees greater discretion and trust over their working hours, amid increasing digital and intelligent tool adoption, may impact individual performance and organizational vitality. The company believes that increasing individuals’ discretionary leisure time is significant for enhancing personal, family, and societal well-being, as well as fostering innovation. As an important part of society, enterprises have a responsibility to engage in practical exploration. Efforts such as hybrid work arrangements, a 50,000-yuan childbirth benefit, and this new "no-questions-asked personal leave" trial represent steps to translate this philosophy into concrete practice.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10